Good “Pharming” Practices: FDA Outlines CMCs For Plant-Made Drugs
Executive Summary
Pharmaceuticals derived from bioengineered plants should include a description of harvesting methods in the chemistry, manufacturing & controls section of NDAs and BLAs, a joint FDA/USDA 1draft guidance on plant-made pharmaceuticals says
You may also be interested in...
BIO Wants Tighter Controls For Plant-Made Drugs, But No Fencing
More details should be required for a permit to grow biotechnology-derived crops, the Biotechnology Industry Organization says in comments on a joint FDA/Department of Agriculture draft guidance on plant-made pharmaceuticals
BIO Wants Tighter Controls For Plant-Made Drugs, But No Fencing
More details should be required for a permit to grow biotechnology-derived crops, the Biotechnology Industry Organization says in comments on a joint FDA/Department of Agriculture draft guidance on plant-made pharmaceuticals
ProdiGene To Develop “Field Trial” Compliance Program Following Violation
ProdiGene is working with FDA and USDA to develop a compliance program as part of a settlement agreement relating to safety violations in the production of plant-made pharmaceuticals